Skip to content

Perampanel for Alleviation of Secondary Injury in Traumatic Brain Injury Trial

Perampanel for Alleviation of Secondary Injury in Traumatic Brain Injury Trial: Phase-II Multicenter Randomized Clinical Trial - PEACE-TBI trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs031250067
Enrollment
100
Registered
2025-04-24
Start date
2025-06-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain Injury contusion, acute subdural hematoma, acute epidural hematoma, traumatic subarchnoid hemorrhage, diffuse axional injury

Interventions

Randomly assign one of the following: Intervention Group (Perampanel Group): Administer oraly 2 mg/day of perampanel within 12 hours of TBI diagnosis. The administration is once daily for 7 days. Co
C551441, C043114
Perampanel, Fosphenytoin, Anti-epileptic drug

Sponsors

Yamamoto Ryo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 18 years or older Traumatic brain injury (TBI) including contusion, acute subdural hematoma, acute epidural hematoma, traumatic subarchnoid hemorrhage, and diffuse axional injury is diagnosed with CT or MRI Glasgow Coma Scale is 9 - 14 on hospital arrival or at the time of TBI diagnosis Consent for study participation is obtained Trial medications can be administered per oral

Exclusion criteria

Exclusion criteria: Patients with epilepsy as a comorbidity Patients who arrive at the hospital more than 24 hours after injury Patients with an Injury Severity Score of 25 or higher Pregnant patients Patients with contraindication for Perampanel administration Patients with contraindication for Fosphenytoin administration Patients deemed unsuitable for the study by the research physician

Design outcomes

Primary

MeasureTime frame
Equal to or more than 5 of GOSE score at 90 days after TBI diagnosis

Secondary

MeasureTime frame
GOSE score at 90 days after TBI diagnosis MMSE score at 90 days after TBI diagnosis Traumatic epilepsy seizures up to 90 days Adverse events up to 90 days GOSE score at 30 days Traumatic epilepsy seizures up to 30 days Hospital-, ICU-, and Ventilator-free days up to 30 days Traumatic epilepsy seizures and adverse events up to 7 days

Contacts

Public ContactRyo Yamamoto

Keio University Hospital

ryoyamamoto@keio.jp+81-332251323

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026